Clinical Trials Directory

Trials / Completed

CompletedNCT04212156

Thyromental Height Test (TMHT) as a Predictor of Difficult Airway in Obese Patients

Validity of Thyromental Height Test (TMHT) as an Objective Predictor of Difficult Airway in Obese Patients: a Prospective Observational Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Difficult airway management is a major concern for anesthetists and contributes to perioperative morbidity and mortality. The incidence of difficult intubation in the obese population with a BMI of greater than 30 has been reported to be 15.8%. Thyromental height test (TMHT) is a new bedside test for difficult airway, it is a measure of the height between the anterior borders of the mentum and thyroid cartilage. TMHT can act as a surrogate for amount of mandibular protrusion; dimensions of submandibular space; and anterior position of the larynx. It appears promising as a single anatomical measure to predict the risk of difficult laryngoscopy.

Conditions

Timeline

Start date
2020-01-20
Primary completion
2020-01-20
Completion
2021-01-20
First posted
2019-12-26
Last updated
2021-05-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04212156. Inclusion in this directory is not an endorsement.

Thyromental Height Test (TMHT) as a Predictor of Difficult Airway in Obese Patients (NCT04212156) · Clinical Trials Directory